Company Performance Metrics
- Past Role: Forest Devices, Co-Founder & Chief Operating Officer
Dan Willis: CTO
For millions living with chronic wounds, recovery is often slow, painful, and disruptive. Patients and clinicians face limited options, and progress in care has not kept pace with the need. Aethl Bio was founded to help change that.
Aethl's platform is built around proprietary hydrogel technology designed to support a sustained normoxic wound
environment. Aethl is pursuing opportunities across global wound care and adjacent categories, including animal health wound and post-surgical care, as well as advanced skincare and cosmeceutical applications. With IP-protected formulations and a scalable platform approach, Aethl Bio is focused on building versatile solutions for chronic wounds, non-healing wounds, and other high-need care settings with related skin-support applications.